165 related articles for article (PubMed ID: 14985167)
1. Australasian CD34+ quality assurance program and rationale for the clinical utility of the single-platform method for CD34+ cell enumeration.
Chang A; Raik E; Marsden K; Ma DD
Cytotherapy; 2004; 6(1):50-61. PubMed ID: 14985167
[TBL] [Abstract][Full Text] [Related]
2. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study.
Gratama JW; Kraan J; Keeney M; Sutherland DR; Granger V; Barnett D
Cytotherapy; 2003; 5(1):55-65. PubMed ID: 12745591
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries.
Levering WH; Preijers FW; van Wieringen WN; Kraan J; van Beers WA; Sintnicolaas K; van Rhenen DJ; Gratama JW
Cytometry B Clin Cytom; 2007 May; 72(3):178-88. PubMed ID: 17397065
[TBL] [Abstract][Full Text] [Related]
4. Single- versus dual-platform assays for human CD34+ cell enumeration.
Barbosa IL; Sousa ME; Godinho MI; Sousa F; Carvalhais A
Cytometry; 1999 Dec; 38(6):274-9. PubMed ID: 10589042
[TBL] [Abstract][Full Text] [Related]
5. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.
Keeney M; Chin-Yee I; Weir K; Popma J; Nayar R; Sutherland DR
Cytometry; 1998 Apr; 34(2):61-70. PubMed ID: 9579602
[TBL] [Abstract][Full Text] [Related]
6. Analysis of commercial CD34 control samples for quality assurance.
Bojko P; Stellberg W; Mansmann V; Seeber S
Clin Lab; 2002; 48(3-4):117-24. PubMed ID: 11934212
[TBL] [Abstract][Full Text] [Related]
7. Use of the haematopoietic progenitor cell parameter in optimizing timing of peripheral blood stem cell harvest.
Padmanabhan A; Reich-Slotky R; Jhang JS; Dael S; Crowder T; Colovai AI; Schwartz J
Vox Sang; 2009 Aug; 97(2):153-9. PubMed ID: 19392781
[TBL] [Abstract][Full Text] [Related]
8. External quality assessment in clinical cell analysis by flow cytometry. Why is it so important?
Siftar Z; Paro MM; Sokolić I; Nazor A; Mestrić ZF
Coll Antropol; 2010 Mar; 34(1):207-17. PubMed ID: 20432753
[TBL] [Abstract][Full Text] [Related]
9. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots.
Flores AI; McKenna DH; Montalbán MA; De la Cruz J; Wagner JE; Bornstein R
Transfusion; 2009 Apr; 49(4):636-47. PubMed ID: 19055702
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers.
Sutherland DR; Nayyar R; Acton E; Giftakis A; Dean S; Mosiman VL
Cytotherapy; 2009; 11(5):595-605. PubMed ID: 19513900
[TBL] [Abstract][Full Text] [Related]
11. Validation of a single-platform method for hematopoietic CD34+ stem cells enumeration according to accreditation procedure.
Massin F; Huili C; Decot V; Stoltz JF; Bensoussan D; Latger-Cannard V
Biomed Mater Eng; 2015; 25(1 Suppl):27-39. PubMed ID: 25538053
[TBL] [Abstract][Full Text] [Related]
12. The impact of erythrocyte lysing procedures on the recovery of hematopoietic progenitor cells in flow cytometric analysis.
Greve B; Beller C; Cassens U; Sibrowski W; Göhde W
Stem Cells; 2006 Mar; 24(3):793-9. PubMed ID: 16210405
[TBL] [Abstract][Full Text] [Related]
13. Correlation of CD34+ cell yield in peripheral blood progenitor cell product with the pre-leukapheresis cell counts in peripheral blood.
Sawant RB; Rajadhyaksha SB
J Assoc Physicians India; 2005 Dec; 53():1031-5. PubMed ID: 16572958
[TBL] [Abstract][Full Text] [Related]
14. Assessing agreement between CD34 enumeration by flow cytometry and volumetric analysis.
Gisselø CG; Roer O; Hoffmann MH; Hansen MB; Taaning E; Johnsen HE
Bone Marrow Transplant; 2002 Apr; 29(8):699-703. PubMed ID: 12180116
[TBL] [Abstract][Full Text] [Related]
15. A new single-platform method for the enumeration of CD34+ cells.
Lemarie C; Bouchet G; Sielleur I; Durand V; Navarro F; Calmels B; Chabannon C
Cytotherapy; 2009; 11(6):804-6, 806.e1. PubMed ID: 19878066
[TBL] [Abstract][Full Text] [Related]
16. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
17. Interlaboratory variability of CD34+ stem cell enumeration. A pilot study to national external quality assessment within the Czech Republic.
Lysák D; Kalina T; Martínek J; Pikalová Z; Vokurková D; Jarešová M; Marinov I; Ondrejková A; Spaček M; Stehlíková O
Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e229-36. PubMed ID: 20561093
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
Burt RK
Stem Cells; 1999; 17(6):373-6. PubMed ID: 10606166
[TBL] [Abstract][Full Text] [Related]
19. Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients.
Bochennek K; Andreas C; Margraf C; Stahlkamp H; Zimmermann S; Esser R; Schwabe D; Klingebiel T; Grüttner HP; Koehl U
Bone Marrow Transplant; 2005 Sep; 36(6):481-9. PubMed ID: 16044142
[TBL] [Abstract][Full Text] [Related]
20. ISHAGE protocol: are we doing it correctly?
Whitby A; Whitby L; Fletcher M; Reilly JT; Sutherland DR; Keeney M; Barnett D
Cytometry B Clin Cytom; 2012 Jan; 82(1):9-17. PubMed ID: 21915992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
